What are the differential diagnoses for a follicular pattern of reactive lymphoid hyperplasia?

Differential Diagnoses for Follicular Pattern of Reactive Lymphoid Hyperplasia

The primary differential diagnosis for a follicular pattern of reactive lymphoid hyperplasia is follicular lymphoma (FL), which can be distinguished through a combination of architectural features, immunophenotyping (particularly BCL-2 expression), and molecular studies for t(14;18) translocation.

Key Differential Diagnoses

1. Follicular Lymphoma (FL) - Most Critical Differential

This is the most important entity to exclude when encountering follicular reactive hyperplasia 1. The distinction relies on several features:

Morphologic Differences:

• Reactive hyperplasia: Preserved nodal architecture with polarized germinal centers showing distinct light and dark zones, tingible body macrophages present, variable follicle sizes and shapes 2, 1
• FL: Effaced architecture with back-to-back follicles, loss of normal polarity, monotonous follicle sizes, predominantly small cleaved cells (centrocytes), "two-nuclei-like cleaved cells" 2

Immunophenotypic Distinctions:

• BCL-2 expression: The single most useful marker - reactive follicles are BCL-2 negative in germinal centers, while FL shows strong BCL-2 positivity in ~85% of cases 3, 1
• CD10 and BCL-6: Both positive in FL and reactive germinal centers, so less discriminatory 4
• Ki-67: Lower proliferation index in FL (typically <30%) versus higher in reactive germinal centers 5, 1
• IgM pattern: Reactive follicles show IgM highlighting FDC processes; FL shows loss of IgM on FDCs with possible increased IgM in tumor cells 6

Molecular Studies:

• t(14;18)(q32;q21) translocation present in ~85% of FL cases 4, 2
• Clonal IgH gene rearrangements in FL versus polyclonal pattern in reactive hyperplasia 1

2. Mantle Cell Lymphoma (MCL)

MCL can occasionally present with a nodular/follicular pattern mimicking reactive hyperplasia 7:

Distinguishing Features:

• CD5+ and cyclin D1+ (or cyclin D2/D3 in rare cyclin D1-negative cases) 7, 3
• t(11;14) translocation 7
• SOX11 nuclear expression in most cases 7
• Monotonous small to medium lymphoid cells without true germinal center formation

3. Marginal Zone Lymphoma (MZL)

Can show follicular colonization patterns 3:

Key Features:

• CD5-, CD10-, BCL-6+/- 3
• Monocytoid B-cell morphology
• May show plasmacytic differentiation
• No t(14;18) translocation

4. Pediatric-Type Follicular Lymphoma (PTFL)

Particularly relevant in children and young adults (age 7-33 years) 8:

Distinguishing Characteristics:

• Expanded serpiginous follicles with starry-sky appearance
• High Ki-67 proliferation index (unlike conventional FL)
• CD10+, BCL-6+, BCL-2 negative (critical difference from adult FL) 8
• MAP2K1 mutations in ~71% of cases 8
• Excellent prognosis, often requires no treatment

5. Progressive Transformation of Germinal Centers (PTGC)

Though not explicitly detailed in the provided evidence, this represents a benign process that can mimic follicular patterns and should be considered in the differential.

6. IgG4-Related Sclerosing Disease

A specific type of reactive follicular hyperplasia 1:

Diagnostic Approach:

• High index of suspicion based on clinical context
• IgG and IgG4 immunostains showing increased IgG4+ plasma cells
• Requires clinical correlation for definitive diagnosis

Diagnostic Algorithm

Step 1: Assess Architecture

• Preserved nodal architecture with polarized follicles → favors reactive
• Effaced architecture with monotonous back-to-back follicles → favors lymphoma

Step 2: Immunophenotyping Panel

• Essential markers: CD20, CD3, CD10, BCL-6, BCL-2, Ki-67
• If CD5+: Add cyclin D1 to exclude MCL 3, 9
• If BCL-2 negative in young patient: Consider PTFL, test for MAP2K1 mutations 8

Step 3: BCL-2 Interpretation

• BCL-2 negative in follicles → strongly favors reactive hyperplasia or PTFL
• BCL-2 positive in follicles → highly suspicious for FL, proceed to molecular studies

Step 4: Molecular Studies (if immunophenotype equivocal)

• FISH for t(14;18) - positive in ~85% of FL 4
• IgH gene rearrangement studies - clonal in lymphoma, polyclonal in reactive 1

Step 5: Additional Studies in Specific Contexts

• Young patients (<35 years): Consider NGS for MAP2K1 mutations if PTFL suspected 8
• CD5+ cases: FISH for t(11;14) to confirm/exclude MCL 7

Common Pitfalls to Avoid

1. Over-reliance on morphology alone: FL grades 1-2 can have small lymphocytes similar in size to reactive lymphocytes in ~50% of cases 2

2. Misinterpreting partial involvement: FL may show focal involvement with preserved reactive areas; ensure adequate sampling 5

3. Ignoring clinical context: Age matters - BCL-2 negative follicular proliferations in children/young adults suggest PTFL rather than reactive hyperplasia 8

4. Core biopsy limitations: Architectural assessment is compromised; excisional biopsy preferred for definitive diagnosis 4

5. False-negative BCL-2: Approximately 15% of FL are BCL-2 negative; don't exclude FL based solely on negative BCL-2 3